Reaction

Petit Mal Epilepsy reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 5,019 reports · 106 co-occurring drugs

As of the last recalculation, Petit Mal Epilepsy appears in 5,019 FAERS reports alongside 106 co-occurring drug terms. The strongest observed disproportionality signal is BRIVARACETAM (PRR 72.7).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Brivaracetam	153	72.7	74.0
Clobazam	325	59.0	59.7
Cenobamate	114	57.9	58.7
Lacosamide	405	49.0	49.5
Levetiracetam	1,047	40.8	41.1
Levetiracetam In Sodium Chloride	655	40.2	40.5
Levetiracetam Oral	655	40.2	40.5
Levetiracetam Injection	655	40.2	40.5
Oxcarbazepine	296	40.1	40.4
Valproic Acid	277	38.5	38.9
Zonisamide	112	32.1	32.3
Valproate Sodium	147	30.4	30.6
Carbamazepine	431	29.1	29.3
Extended Phenytoin Sodium	107	27.1	27.2
Lamotirigine	408	25.6	25.8
Lamotrigine Extended-Release	408	25.6	25.8
Lamotrigine Chewable Dispersible	408	25.6	25.8
Lamotrigine	696	25.3	25.4
Phenobarbital	86	25.0	25.2
Cannabidiol	136	24.7	24.9
Primidone	54	22.2	22.3
Topiramate	387	18.6	18.6
Divalproex Sodium	182	16.8	16.9
Phenytoin	69	13.9	13.9
Vigabatrin	42	12.0	12.1
Midazolam	54	9.0	9.0
Memantine	28	8.5	8.5
Memantine Hydrochloride	28	8.5	8.5
Midazolam Hydrochloride	49	7.6	7.6
Bisacodyl Suppositories	18	5.8	5.8
Biscodyl	18	5.7	5.7
Quinine	11	5.3	5.3
Bisacodyl	18	5.3	5.3
Sotalol Hydrochloride	20	5.0	5.0
Atomoxetine Hydrochloride	28	4.9	4.9
Methylphenidate Hydrochloride	69	4.9	4.9
Clonazepam	183	4.9	4.9
Acetylcysteine	11	4.8	4.9
Diazepam	135	4.7	4.7
Gentamicin	14	4.4	4.5
Diazepam Oral Solution (Concentrate)	94	4.4	4.4
Diazepam Oral	94	4.4	4.4
Haloperidol Lactate	26	4.4	4.4
Haloperidol	25	4.3	4.3
Guanfacine	8	4.2	4.2
Olanzapine	106	4.2	4.2
Telmisartan	17	4.0	4.0
Gentamicin Sulfate	15	3.9	3.9
Desloratadine	10	3.9	3.9
Rivastigmine	17	3.8	3.8
Sertraline	100	3.6	3.6
Melatonin	46	3.5	3.5
Ropinirole	13	3.5	3.5
Donepezil Hydrochloride	31	3.5	3.5
Mesna Injection	7	3.5	3.5
Amantadine	13	3.5	3.5
Mesna	7	3.5	3.5
Calcium, Magnesium, Potassium, And Sodium Oxybates	7	3.4	3.4
Metolazone	9	3.3	3.3
Aripiprazole Oral	32	3.2	3.2
Aripiprazole Orally Disintegrating	32	3.2	3.2
Ganciclovir Sodium	8	3.1	3.1
Clozapine	93	3.1	3.1
Botulinum Toxin Type A	9	3.0	3.0
Rasagiline Mesylate	8	3.0	3.0
Cefepime	10	2.9	2.9
Fosaprepitant Dimeglumine	9	2.7	2.7
Modafinil	21	2.7	2.7
Vilazodone Hydrochloride	6	2.7	2.7
Cariprazine	6	2.7	2.7
Posaconazole Delayed-Release	7	2.6	2.6
Ziprasidone Mesylate	9	2.6	2.6
Leucovorin Calcium	12	2.6	2.6
Ziprasidone	11	2.6	2.6
Methylphenidate	18	2.6	2.6
Cefepime Hydrochloride	10	2.6	2.6
Dutasteride	5	2.6	2.6
Blinatumomab	6	2.4	2.4
Interferon Beta-1A	107	2.3	2.3
Fentanyl Citrate	10	2.3	2.3
Aripiprazole	68	2.3	2.3
Risperidone	73	2.3	2.3
Rimegepant Sulfate	7	2.3	2.3
Aprepitant	10	2.2	2.2
Fluorouracil Cream, 0.5%	41	2.2	2.2
Fluorouracil	41	2.2	2.2
Asfotase Alfa	5	2.1	2.1
Sevoflurane	4	2.0	2.0
Ethyl Alcohol	13	2.0	2.0
Irinotecan Hydrochloride	6	1.9	1.9
Peginterferon Beta-1A	6	1.9	1.9
Isopropyl Alcohol	15	1.8	1.8
Paliperidone	10	1.8	1.8
Elexacaftor, Tezacaftor, And Ivacaftor	5	1.7	1.7
Alcohol	13	1.4	1.4
Palivizumab	5	1.4	1.4
Somatropin	21	1.2	1.2
Drospirenone And Ethinyl Estradiol	12	1.1	1.1
Dalfampridine	17	1.0	1.0
Natalizumab	41	0.9	0.9
Esketamine Hydrochloride	4	0.9	0.9
Tapentadol Hydrochloride	7	0.9	0.9
Erenumab-Aooe	11	0.8	0.8
Droxidopa	4	0.8	0.8
Galcanezumab-Gnlm	5	0.7	0.7
Levonorgestrel	27	0.6	0.6

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.